Detwiler Fenton Investment Management’s Novo Nordisk NVO Stock Holding History

Detwiler Fenton Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.01M	Sell	36,816 -144,272	-80%	-$4.06M	3.25%	6
2015 Q1	$4.83M	Sell	181,088 -12,198	-6%	-$281K	5.08%	4
2014 Q4	$4.09M	Sell	193,286 -8,082	-4%	-$181K	4.62%	7
2014 Q3	$4.79M	Sell	201,368 -284	-0.1%	-$6.54K	4.57%	4
2014 Q2	$4.66M	Sell	201,652 -8,872	-4%	-$196K	3.76%	4
2014 Q1	$4.8M	Buy	+210,524	New	+$4.49M	4.15%	2

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Detwiler Fenton Investment Management's NVO Position: Q2 2015 in Review

Detwiler Fenton Investment Management reduced its Novo Nordisk (NVO) stake by 80% in Q2 2015, selling an estimated $4.06M and leaving 36,816 shares worth $1.01M. The position accounts for 3.25% of the portfolio, ranked #6.

Detwiler Fenton Investment Management first reported a position in NVO in Q1 2014 and has held it in 6 quarters since. The position peaked at $4.83M in Q1 2015. 517 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

Detwiler Fenton Investment Management held 36,816 shares of Novo Nordisk worth $1.01M as of Q2 2015.
Detwiler Fenton Investment Management sold 144,272 Novo Nordisk shares in Q2 2015, an estimated $4.06M.
Novo Nordisk made up 3.25% of Detwiler Fenton Investment Management's portfolio in Q2 2015, its #6 holding.
Detwiler Fenton Investment Management first reported a position in Novo Nordisk in Q1 2014 and has held it in 6 quarters since.
Detwiler Fenton Investment Management's Novo Nordisk position peaked at $4.83M in Q1 2015.
517 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Detwiler Fenton Investment Management's 13F filing for Q2 2015, filed 29 Jul 2015.